Hybrid mass spectrometry methods reveal lot-to-lot differences and delineate the effects of glycosylation on the tertiary structure of Herceptin®. (2019)

First Author: Upton R

Attributed to: Future Biomanufacturing Research Hub funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c8sc05029e

PubMed Identifier: 30997002

Publication URI: http://europepmc.org/abstract/MED/30997002

Type: Journal Article/Review

Volume: 10

Parent Publication: Chemical science

Issue: 9

ISSN: 2041-6520